SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1592)1/29/2003 2:37:03 PM
From: tuck  Respond to of 1728
 
That $30 million round is the only one since the first one. I would guess that AFFX' stake is now in the ballpark of 40%. The next 10Q, which should be out in a weeks, should provide more details. The basis for my speculation comes from this post:

Message 17014953

This latest round may have the effect of allowing AFFX to remove the chunk that was in a voting trust, though that makes little material difference.

Cheers, Tuck



To: Jibacoa who wrote (1592)1/29/2003 6:13:50 PM
From: tuck  Read Replies (1) | Respond to of 1728
 
Looks like I called that one pretty well; we don't even have to wait for the 10-Q. From today's PR:

>>As a result of this financing, Affymetrix' equity ownership now stands at approximately 43%, which allows Affymetrix to eliminate the voting trust in which a portion of Affymetrix' interest in Perlegen was held.<<

Link to full PR:

Message 18509614

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News